Literature DB >> 17674001

Acute myositis in a patient with systemic sclerosis after the administration of darbepoetin alpha.

C Palazzi1, L D'Agostino, S D'Angelo, A Petricca, I Olivieri.   

Abstract

We first describe the onset of acute myositis in a patient suffering from systemic sclerosis after the administration of darbepoetin alpha for renal failure-related anemia. Therapeutic implications and risks are discussed.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17674001     DOI： 10.1007/s00296-007-0430-6

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN： 0172-8172            Impact factor:   2.631


  11 in total

Review 1.  Dermatomyositis and drugs.

Authors:  A L Dourmishev; L A Dourmishev
Journal:  Adv Exp Med Biol       Date:  1999       Impact factor: 2.622

2.  Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin.

Authors:  Nicole Casadevall; Joelle Nataf; Beatrice Viron; Amir Kolta; Jean-Jacques Kiladjian; Philippe Martin-Dupont; Patrick Michaud; Thomas Papo; Valerie Ugo; Irene Teyssandier; Bruno Varet; Patrick Mayeux
Journal:  N Engl J Med       Date:  2002-02-14       Impact factor: 91.245

3.  Hypersensitivity reactions to the polysorbate contained in recombinant erythropoietin and darbepoietin.

Authors:  Richard H Steele; Sandhya Limaye; Bruce Cleland; Josephine Chow; Michael G Suranyi
Journal:  Nephrology (Carlton)       Date:  2005-06       Impact factor: 2.506

Review 4.  Antibody-mediated pure red cell aplasia (PRCA): epidemiology, immunogenicity and risks.

Authors:  Iain C Macdougall
Journal:  Nephrol Dial Transplant       Date:  2005-05       Impact factor: 5.992

5.  Renal involvement in patients with polymyositis and dermatomyositis.

Authors:  T-H Yen; P-C Lai; C-C Chen; S Hsueh; J-Y Huang
Journal:  Int J Clin Pract       Date:  2005-02       Impact factor: 2.503

6.  Muscle disease in progressive systemic sclerosis: diagnostic and therapeutic considerations.

Authors:  P J Clements; D E Furst; D S Campion; A Bohan; R Harris; J Levy; H E Paulus
Journal:  Arthritis Rheum       Date:  1978 Jan-Feb

7.  Case-control study of corticosteroids and other drugs that either precipitate or protect from the development of scleroderma renal crisis.

Authors:  V D Steen; T A Medsger
Journal:  Arthritis Rheum       Date:  1998-09

Review 8.  Erythropoietin: physiology and pharmacology update.

Authors:  James W Fisher
Journal:  Exp Biol Med (Maywood)       Date:  2003-01

9.  Allergic skin and systemic reactions in a patient with pure red cell aplasia and anti-erythropoietin antibodies challenged with different epoetins.

Authors:  Gertrud Weber; Johann Gross; Arno Kromminga; Hans-H Loew; Kai-Uwe Eckardt
Journal:  J Am Soc Nephrol       Date:  2002-09       Impact factor: 10.121

Review 10.  Differential diagnosis of idiopathic inflammatory myopathies.

Authors:  Alan N Baer
Journal:  Curr Rheumatol Rep       Date:  2006-06       Impact factor: 4.686
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.